In patients affected with anal cancer and treated with concurrent chemo-radiation (CT-RT), our group highlighted the prognostic value of the Systemic Index of Inflammation (SII) [14], low baseline Hb level [8], and high baseline eosinophil level [15] in predicting for poor response to CT-RT. Here, GSTM1 is linked to anal carcinoma.